Stock image of a researcher The California Institute for Regenerative Medicine (CIRM) approved $25 million to fund multiple projects across discovery research, clinical research, and infrastructure programs. In particular, this funding supports 11 projects that will drive rigorous studies addressing key knowledge gaps in stem cell biology and regenerative medicine. Through this work, the program … Continue reading CIRM awards $25 million for research and infrastructure programs
infrastructure
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
A laboratory at UCLA's current good manufacturing practices facility | Photo credit: Elena Zhukova The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $10 million to five facilities as part of the first phase to build a California Cell and Gene Therapy Manufacturing Network. The awards include: Application … Continue reading CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
Apply Now for New Manufacturing Funding Opportunity
The California Institute for Regenerative Medicine (CIRM) has set goals through its five-year strategic plan to continue to deliver the full potential of regenerative medicine to the people of California and around the world. One of those goals is to overcome manufacturing hurdles for the delivery of regenerative medicine therapies by building a public-private manufacturing … Continue reading Apply Now for New Manufacturing Funding Opportunity
Building California’s stem cell research community, from the ground up
For week three of the Month of CIRM, our topic is infrastructure. What is infrastructure? Read on for a big picture overview and then we’ll fill in the details over the course of the week. When CIRM was created in 2001, our goal was to grow the stem cell research field in California. But to … Continue reading Building California’s stem cell research community, from the ground up